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ffer at the diagnostic places and at the countries of ori-
in, widening the contact investigation, raising the directly
bserved treatment rate and decreasing the TB default.
hose actions will strengthen the TB surveillance system in
trategic areas contributing to the better understanding of
he migration ﬂows for TB treatment in neighbor countries.
oi:10.1016/j.ijid.2010.02.2115
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rends in pediatric bacterial meningitis in Sudan 2005-
006
.H. Mahmoud1,∗, M.E.M. Alkarsani2
Alzaem Alazhari University, faculty of medical laboratory
ciences, khartoum north, Sudan
National Reference laboratory, Stack, khartoum, Sudan
Background: Asurvellance of epidemiological pediatric
acterial meningitis was carried out between January 2005
nd january 2006 in sudan, in National Reference Laboratory.
Methods: 932 CSF samples were collected from children
uspected having bacterial meningitis, gram stain, culture,
iochemical tests and serotybing was done,
Results: with the following results: Bacterial meningi-
is cases numbered (46 boys, 32 girls), from atotal of 932
hilds suspected having bacteral meningitis. The age dis-
ribution for the infections was the highest under 2 year of
ge, decreasing with increasing age. N. meningitides was the
ost common pathogen, followed by Haemophilus inﬂuen-
ae, Streptococcus pneumoniae, Staphellococus aureus(one
solate). The relationship between causactive pathogens
nd age distribution was as follows: staph aureus was iso-
ated from child of 6 months of age and H. inﬂuenzae and
. pneumoniae were major pathogens less than 5 years
f age.where meningococci were from mor than 5 years
f age.Susceptibility tests demonstrated that. 60% of H.
nﬂuenzae isolates and. 58% of S. pneumoniae isolates were
rug-resistant.
Conclusion: Ceftriaxone an affective againest meningo-
occi,where chloramphenicol antibiotics are currently less
ffective a combination of ampicillin and cephem antibi-
tics is used ﬁrst line at many facilities for patients below 4
onths of age. A combination of carbapenem which showed
ffective against PRSP and cephem which showed effective
gainst H. inﬂuenzae is the ﬁrst choice in childhood bacterial
eningitis for patients above 4 months of age.
oi:10.1016/j.ijid.2010.02.2116
‘
e
s
e
s
e
o
c
n
a
r
t
t
s
e
dternational Congress on Infectious Diseases (ICID) Abstracts
7.034
limination of neglected diseases in Latin America and the
aribbean: A mapping of selected diseases
.C. Schneider1, X.P. Aguilera1, J. Barbosa da Silva Jr.1,∗,
.K. Ault1, P. Najera1, J. Martinez1, R. Requejo1, R.S.
icholls 1, Z. Yadon1, J.C. Silva2, L.F. Leanes3, M. Roses
eriago1
Pan American Health Organization, Washington DC, DC,
SA
Organización Panamericana de la Salud, Bogota DC, Colom-
ia
Centro Panamericano de Fiebre Aftosa PANAFTOSA, Rio de
aneiro, Brazil
Background: In Latin America and the Caribbean, around
95 million people live in poverty, a situation that increases
he burden of some infectious diseases. Neglected diseases,
n particular, are often restricted to poor, marginalized
ections of the population. Most cause chronic conditions,
hich in turn reduce learning capabilities, productivity and
ncome earning capacity. Cost-effective tools exist to com-
at these diseases, making it imperative to work towards
heir elimination. In 2009, the Pan American Health Organi-
ation received a mandate to support the countries in the
egion in eliminating neglected diseases and other pover-
yrelated infections.
Methods: This study analyzed and determined which
ountries in the Region exhibit evidence of selected poverty-
elated diseases, determine areas where particular diseases
oexist, and detect ‘‘hotspots’’ where countries can imple-
ent interprogrammatic and intersectoral approaches. Five
iseases with available information were analyzed using
eoprocessing techniques at the ﬁrst subnational level
states), identifying the presence and overlap of these dis-
ases.
Results: In the Region, there are approximately 570
tates. Lymphatic ﬁlariasis is present in four countries (29
tates), onchocerciasis in six countries (25 states), schisto-
omiasis in four countries (39 states), trachoma in three
ountries (29 states), and human rabies transmitted by
ogs in ten countries (20 states). The information indi-
ates that 102 of the 570 states have one or more of the
elected neglected diseases, thus they may be considered
‘hotspots’’ in the Region. 33 states present two of the dis-
ases, 2 states present three of the diseases, and only one
tate has evidence of four of the selected neglected dis-
ases, classifying these areas as the major ‘‘hotspots.’’
Conclusion: The analysis suggests a majority of the
elected diseases are not widespread and can be consid-
red part of an unﬁnished agenda with the elimination
f neglected diseases as its goal. Integrated plans and a
omprehensive approach, ensuring access to existing diag-
ostic and treatment tools, and establishing a multi-sectoral
genda that addresses social determinants of disease, are
equired. More speciﬁc baselines are needed for most of
he diseases included in the study and criteria to measure
he presence of some diseases need to be reviewed. Future
tudies can include additional diseases, socioeconomic and
nvironmental variables.
oi:10.1016/j.ijid.2010.02.2117
